Favourites   Have ideas?

Positive:   Disease: Infectious ↓9.8   Biopharma ↓8.66   Medicine ↓2.15 «See more»   Dermatology ↑6.98   Beauty ↑6.99   Women Health ↑8.22

Negative:


Skin segment

ARQT TR» TW» GGL» QArcutis Biotherapeutics, Inc. - Common stock + My List -0.58% down 11% -11.58 + Skin, Medicine

CARA TR» TW» GGL» GCara Therapeutics, Inc. - Common Stock + My List 6.98% down 9.48% -2.5 + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology


Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat
CUTR TR» TW» GGL» QCutera, Inc. - Common Stock + My List 8.22% up 7.95% 0.27 + Skin, Beauty, Women Health

DMTK TR» TW» GGL» SDermTech, Inc. - Common Stock + My List 5.52% down 7.34% -1.82 + Medicine, Cancer fight, Skin

FBRX TR» TW» GGL» SForte Biosciences, Inc. - Common Stock + My List -9.8% down -9.17% -0.63 + Skin, Medicine, Disease: Infectious, Biopharma

GALT TR» TW» GGL» SGalectin Therapeutics Inc. - Common Stock + My List -1.62% down 8.11% -9.73 + Cancer fight, Disease: Liver, Skin, Medicine


Last highlighted: FORM 8-K [Press/News Current Report] recently SEC filed. $GALT $PRWP $GALTU $GALTW GALECTIN THERAPEUTICS INC https://t.co/BT17VmuspR
HOTH TR» TW» GGL» SHoth Therapeutics, Inc. - Common Stock + My List -7.51% down -5.78% -1.73 + Medicine, Biopharma, Skin

ONVO TR» TW» GGL» SOrganovo Holdings, Inc. - Common Stock + My List -6.32% up -7.82% 1.5 + Medicine, Skin

SRTS TR» TW» GGL» SSensus Healthcare, Inc. - Common Stock + My List -11.79% -11.79% 0 + Skin, Medicine

VERO TR» TW» GGL» GVenus Concept Inc. - Common Stock + My List 5.76% down 7.79% -2.03 + Medicine, Devices, Beauty, Skin


Last highlighted: New Form 10-Q [Quarterly Report] entry filed by $VERO $HAIR Venus Concept Inc. Venus Concept Inc https://t.co/Z132OKt88a


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.